Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia. - Wikidata - wikimedia - TriplyDB

Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.

Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.

http://www.wikidata.org/entity/Q35377371

about

microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment MicroRNAs in B-cells: from normal differentiation to treatment of malignancies Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs Circulating microRNAs: potential biomarkers for common malignancies Aberrant regulation of FBW7 in cancer.MicroRNA: important player in the pathobiology of multiple myeloma MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θ.miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema.Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type.Shielding the messenger (RNA): microRNA-based anticancer therapies.A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma.The two faces of FBW7 in cancer drug resistance.Tumor suppressor functions of FBW7 in cancer development and progression.Association between pre-miR-27a functional polymorphism and risk of colorectal cancer in north Chinese Han population.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy Mechanisms of doxorubicin resistance in hepatocellular carcinoma Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance.MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1 Regulation of multidrug resistance by microRNAs in anti-cancer therapy Drug resistance-related microRNAs in esophageal cancer.miRNAs as mediators of drug resistance.Friend or foe: the role of microRNA in chemotherapy resistance.Hematological malignancies: role of miRNAs and their in silico aspects.The network of P-glycoprotein and microRNAs interactions.MicroRNAs and their relevance to ABC transporters.MicroRNAs and drug resistance in prostate cancers.MDR1 will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks.Membrane microparticles: shedding new light into cancer cell communication.The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo.Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures.Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion.The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy.Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells.Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.Alpha-2, 3-sialyltransferases regulate the multidrug resistance of chronic myeloid leukemia through miR-4701-5p targeting ST3GAL1.Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistance.

P2860

Q26778918-B146D063-677E-47EA-8D67-241A7B9D825C Q26824682-C56A6823-9C30-44E5-B711-703D64754E4B Q28071427-C0EA0CB1-857F-4460-B750-0640CE9E9070 Q28081347-BDBEFF84-74EA-4A61-AD05-96690FF64C0B Q33688508-E752C8A4-97BC-4F54-95B4-AE3EF32D8C09 Q33786861-CF48F382-1738-48BE-B910-E88D9E4E4525 Q34154782-ABF89569-B860-4489-8ABF-77BB9CE5637C Q34217173-A7BD3227-A575-40DF-B132-294F7B54A20E Q34510548-139DC4FD-FE3C-4AE0-A4C0-71C8AAA36639 Q34545051-DB066D03-CE7B-4186-AB0E-976C22C9535D Q35051303-E1BCC886-402C-44B3-BE16-149CB557F99A Q35070602-7A924FDF-0510-4017-B9EF-09F2AF032A45 Q35176459-C1AA3596-665C-43E6-8A28-717F87EDAFCC Q35999467-C86322E1-DF44-4CD6-8F80-ED125DCF7FF9 Q36025441-B3D3F977-08D6-4ACB-B54B-B29C491F999B Q36208406-71B21DDF-5F3D-4B51-9FA7-A8DC11E92056 Q36602853-50F500B2-BD85-484F-BF15-EE6829CBDF59 Q36618667-B2193C47-A2C6-47E8-B223-F656FCAF6FC0 Q36687760-9EA23D10-5DCD-4C20-ADEA-54384E847FFF Q36812554-2F2B4C37-8A10-43AE-802D-4DA82A5B5A2C Q37013255-F4CB5040-0036-40BD-AB98-5ABCE6FB0E9E Q37295313-3B2929E9-DFB5-4B3C-AF4D-8127067A8EBB Q37587311-1A4E98BC-FC03-4CF7-8612-C2BD4D74BABD Q38029108-908DB44A-E5DB-4562-811D-62547D215098 Q38037620-E8E591AF-F08A-4844-A96F-5F52174D03D7 Q38102553-EF791045-184E-4108-ABDD-C6B24946700D Q38140001-4D511539-3673-4D38-86C9-5062210726C5 Q38152293-90984733-9671-4266-B6F0-71028A0809B5 Q38197247-A0A41017-8FE3-4F3A-A9DE-D05D77FD0612 Q38205266-8D9E9C35-ADD1-41A3-BC9E-48047D16C7C9 Q38339659-F1241A1C-2156-4903-BB64-F0D08B0AB2DC Q38569109-37AF46C5-5656-4500-B1B7-A386C7A71315 Q38620165-C1B477F8-59A1-4FEA-ABD8-8516BE39C8B3 Q38676889-79F386A3-7722-4B15-B708-86F73C72740D Q38698665-FA8FAC9B-2B02-4597-BDAA-6F276F946FC3 Q38710597-86975165-306C-41D0-A879-66A0F2228904 Q38749023-5BFD8956-BA21-4AD2-BE00-274C813CD274 Q38755213-EB0BB9FA-F15E-4E52-8315-5C79AB8C61B8 Q38777437-67CD8A40-22EC-456F-A006-DE1B47BBA6E1 Q38792633-2ECA3F9F-85B3-4103-BF5E-5DD0EEE980FC

P2860

Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.

http://www.wikidata.org/entity/Q35377371

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Down-regulated miR-331-5p and ...... ance and relapse in leukaemia.

@ast

Down-regulated miR-331-5p and ...... ance and relapse in leukaemia.

@en

type

label

Down-regulated miR-331-5p and ...... ance and relapse in leukaemia.

@ast

Down-regulated miR-331-5p and ...... ance and relapse in leukaemia.

@en

prefLabel

Down-regulated miR-331-5p and ...... ance and relapse in leukaemia.

@ast

Down-regulated miR-331-5p and ...... ance and relapse in leukaemia.

@en

P1433

Q35377371-8A04D325-66DB-413F-832F-7A86C6A75BE6

P1476

Q35377371-65FE7A6D-F3CF-4D65-A4FB-0E2FD54DC37F

P2093

Q35377371-3BA7E978-8341-405E-B5EE-934875656F67

Q35377371-5F2EEC7C-297D-4ACD-82C5-0E6C32B6494C

Q35377371-98426B0D-86F9-4B0F-962F-C10A1C8BB36F

Q35377371-9AA05025-5BC5-4D02-9CC5-368BAC2460BF

Q35377371-9D76321A-AAE9-4861-AC23-5FC6789C45DC

Q35377371-A123A2DE-09E5-4E94-85BC-5524AA930D3E

Q35377371-B1AB58A8-6A7C-4213-9769-80C258A35988

Q35377371-E576BA5D-6F13-476A-8A79-76B0EF05B2F1

Q35377371-FC248858-EC6F-4897-B4B9-8B136DB37E1B

Q35377371-FD95C8F8-503D-4DD8-8F9B-4797388E4EF1

P2860

Q35377371-06CBFE47-7F18-4A33-A9DE-D142405E2941

Q35377371-0B6D1818-C600-44C3-89E1-59D275A7B3B0

Q35377371-12236150-9359-46C0-8136-B926313A8944

Q35377371-1839C4FF-2168-4C2C-B396-7F4663C5E310

Q35377371-1ECFCC35-C3C0-4A8A-9982-2AF345ACAC6F

Q35377371-2C424ACC-A5A1-4AB5-AB4F-4ECF285A0046

Q35377371-332901A0-5A59-4617-BE67-005529EE94DF

Q35377371-351F120B-093B-483B-A36B-3696FDB3DF5A

Q35377371-3728BB78-ED6F-4898-ACC7-176E63B33943

Q35377371-3C08045B-1968-4E41-A077-026E9D30439D

P304

Q35377371-A7F0DD64-9A2C-4CCE-8B84-4CEB47618BFA

P31

Q35377371-D97219F8-0D98-41A5-B139-AD0B368F59A3

P356

Q35377371-189B07A4-13AB-4787-AFB0-EB7061A28847

P433

Q35377371-8E8BF827-E6FD-491E-9DC0-56BEF561F34C

P478

Q35377371-1B23F3F8-2C6D-4BF6-8E7D-56096596F17E

P50

Q35377371-E19AA5DC-C122-4ABC-9D04-42B46AF9680A

P577

Q35377371-BCEA2DD4-21F8-40A6-942E-824BCBA64C06

P5875

Q35377371-15082FEB-E90A-4AEC-8650-E0D8F9F891C5

P698

Q35377371-8B9DF24B-E0D8-4357-A36E-CC068E93156F

P921

Q35377371-7F5FCDE8-89A7-4280-A586-55E6F1D9B615

Q35377371-E5DD4856-39AA-4D8F-91DB-DEE9F8CE87D1

P932

Q35377371-AD110D4C-06E9-4555-90C8-12E0DB24E676

P356

J.1582-4934.2010.01213.X

P1433

Journal of Cellular and Molecular Medicine

P1476

Down-regulated miR-331-5p and ...... ance and relapse in leukaemia.

@en

P2093

Bo-Wei Han

http://www.w3.org/2001/XMLSchema#string

Dan-Dan Feng

http://www.w3.org/2001/XMLSchema#string

Hua Zhang

http://www.w3.org/2001/XMLSchema#string

Hui Zhou

http://www.w3.org/2001/XMLSchema#string

Ling Xu

http://www.w3.org/2001/XMLSchema#string

Peng Zhang

http://www.w3.org/2001/XMLSchema#string

Xing-Ju Zhang

http://www.w3.org/2001/XMLSchema#string

Xue-Qun Luo

http://www.w3.org/2001/XMLSchema#string

Yu-Sheng Zheng

http://www.w3.org/2001/XMLSchema#string

Yue-Qin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals

Cluster analysis and display of genome-wide expression patterns

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

Epigenetics as a mechanism driving polygenic clinical drug resistance

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

MicroRNAs: genomics, biogenesis, mechanism, and function

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

Promotion of reprogramming to ground state pluripotency by signal inhibition

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

P304

2164-2175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2010.01213.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47754550

http://www.w3.org/2001/XMLSchema#string

P698

21070600

http://www.w3.org/2001/XMLSchema#string

P921

P932

4394226

http://www.w3.org/2001/XMLSchema#string